TLN-254

N/A

Report date: 2024/12/16 20:00:57
NME

Base Information

Drug NameTLN-254
Drug Alias NameTLN-254
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, Non-HodgkinLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTreeline Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesTreeline Biosciences Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-HodgkinLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A